FDA Inspection 1210251 — Teva API India Private Ltd.
The FDA completed an inspection of Teva API India Private Ltd. on July 18, 2023 in Gajraula, Amroha. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 18, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gajraula, Amroha (India)